KIF16b Antibody
Affinity Purified Rabbit Polyclonal Antibody (Pab)
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| IHC-P, WB, E |
---|---|
Primary Accession | Q96L93 |
Other Accession | B1AVY7, NP_078980.3 |
Reactivity | Human |
Predicted | Mouse |
Host | Rabbit |
Clonality | Polyclonal |
Isotype | Rabbit IgG |
Calculated MW | 152011 Da |
Antigen Region | 1-30 aa |
Gene ID | 55614 |
---|---|
Other Names | Kinesin-like protein KIF16B, Sorting nexin-23, KIF16B, C20orf23, KIAA1590, SNX23 |
Target/Specificity | This KIF16b antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from human KIF16b. |
Dilution | WB~~1:1000 IHC-P~~1:10~50 |
Format | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | KIF16b Antibody is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | KIF16B |
---|---|
Synonyms | C20orf23, KIAA1590, SNX23 |
Function | Plus end-directed microtubule-dependent motor protein involved in endosome transport and receptor recycling and degradation. Regulates the plus end motility of early endosomes and the balance between recycling and degradation of receptors such as EGF receptor (EGFR) and FGF receptor (FGFR). Regulates the Golgi to endosome transport of FGFR-containing vesicles during early development, a key process for developing basement membrane and epiblast and primitive endoderm lineages during early postimplantation development. |
Cellular Location | Cytoplasm, cytoskeleton. Early endosome membrane. Cytoplasm. Cytoplasm, cytoskeleton, spindle. Note=It is unclear whether association with endosomes is mediated via phosphatidylinositol 3-phosphate (PtdIns(3)P)-binding or via its interaction with RAB14 |
Tissue Location | Primarily expressed in brain. Also present in kidney, liver, intestine, placenta, leukocytes, heart and skeletal muscle (at protein level). |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
KIF16b may be involved in several stages of intracellular trafficking. Probable microtubule-dependent motor protein (By similarity).
References
Vasilescu, J., et al. J. Proteome Res. 6(1):298-305(2007)
Seet, L.F., et al. Biochim. Biophys. Acta 1761(8):878-896(2006)
Miki, H., et al. Trends Cell Biol. 15(9):467-476(2005)
Hoepfner, S., et al. Cell 121(3):437-450(2005)
Worby, C.A., et al. Nat. Rev. Mol. Cell Biol. 3(12):919-931(2002)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.